⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexylene Glycol SCHEMBL123432 | 0.97 | — | — | |
| Hexylene Glycol SCHEMBL335683 | 0.97 | — | — | |
| Hexylene Glycol SCHEMBL6869929 | 0.97 | MAPK1 (0.39) | — | |
| Hexylene Glycol SCHEMBL19379 | 0.97 | — | — | |
| Hexylene Glycol SCHEMBL1829463 | 0.94 | MAPK1 (0.38) | — | |
| Hexylene Glycol SCHEMBL8503452 | 0.94 | — | — | |
| Hexylene Glycol SCHEMBL1828185 | 0.94 | — | — | |
| Hexylene Glycol SCHEMBL11802241 | 0.94 | — | — | |
| Hexylene Glycol SCHEMBL28560190 | 0.94 | — | — | |
| Hexylene Glycol SCHEMBL28176298 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004032963-A9 | PHOTOKINETIC DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES USING PULSED INCOHERENT LIGHT | PHOTOKINETIX INC (US) | 2005-04-28 | — | — | WO | claimed |
| US-12636309-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12636308-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-20250249031-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2025-08-07 | — | — | US | disclosed |
| US-20250249030-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2025-08-07 | — | — | US | disclosed |
| EP-4580751-A2 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | Adora Animal Health Corporation (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12303528-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2025-05-20 | — | — | US | disclosed |
| US-12268708-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240350532-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-10-24 | — | — | US | disclosed |
| US-20240342208-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-10-17 | — | — | US | disclosed |
| US-12059430-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-08-13 | — | — | US | disclosed |
| WO-2024072942-A2 | SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20240108648-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-04-04 | — | — | US | disclosed |
| US-20220273919-A1 | INTRAVAGINAL DEVICES, COMPOSITIONS AND METHODS TO TREAT ATROPHIC VAGINITIS | FEMWELL LLC | 2022-09-01 | — | — | US | disclosed |
| EP-4003485-A1 | INTRAVAGINAL DEVICES, COMPOSITIONS AND METHODS TO TREAT ATROPHIC VAGINITIS | Photokinetix Holdings Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-102675758-B | Oil-absorbing resin and preparation method thereof | UNIV HENAN SCIENCE & TECH | 2014-04-02 | — | — | CN | disclosed |
| CN-101676251-A | Method for synthesizing neopentyl glycol | JINLAI HU | 2010-03-24 | — | — | CN | disclosed |
| CN-1140411-C | Hot-air ink-jet printing head with high heat-transferring efficiency | 李韫言 | 2004-03-03 | — | — | CN | disclosed |
| CN-1262998-A | Hot-air ink-jet printing head with high heat-transferring efficiency | LI YUNYAN (CN) | 2000-08-16 | — | — | CN | disclosed |